Docs: Pulmonary rehabilitation can help patients with lung diseases
Prayagraj: The rising cases of lung diseases are primarily attributed to pollution, smoking and poor lifestyle choices. Patients with
chronic obstructive pulmonary disease
(
COPD
), ILD,
asthma
, lung disease and
lung cancer
often struggle with breathing difficulties.
In such situations,
pulmonary rehabilitation
is a treatment that helps improve the quality of life of these patients, said senior chest physician Dr Gaurav Agrawal, speaking at a CME programme at Allahabad Medical Association (AMA) Convention Centre on Sunday.
During his lecture titled Pulmonary Rehabilitation-- Beyond Medication, Agrawal said, "This treatment focuses on exercise,
respiratory techniques
, diet and mental health. The aim of this process is to increase the breathing capacity of patients and improve energy levels."
Dr Agrawal emphasised that "It can be lifesaving, especially for those who have to be hospitalised frequently due to respiratory problems."
The programme concentrated on enhancing patients' physical capabilities. Experts explained, "Exercise programmes focus on improving patients' physical and mental capacity. Respiratory techniques also improve the breathing capacity of patients, which allows the use of oxygen more effectively."
The comprehensive programme addresses mental health concerns, stress management and proper nutrition. Benefits include enhanced breathing, increased physical endurance, improved mental wellbeing, better ability to perform daily activities, and strengthened muscles for managing lung conditions.
Notable participants included Dr JV Rai, Dr Ashish Tandon, Dr Ashutosh Gupta, Dr Sujit Singh, Dr Anoop Chauhan and Dr Atul Dubey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
Not a virus or bacteria, but this silent killer is spreading and climate change is helping it thrive
Scientists are raising serious concerns over the global spread of a dangerous fungus that can fatally damage human organs, particularly the lungs. Known as Aspergillus, this airborne mold is now spreading at a faster rate, with researchers warning that climate change is creating ideal conditions for it to thrive. The fungus poses a significant threat to public health , especially to people with weakened immune systems, and may soon impact millions across continents. How Aspergillus Affects Humans Aspergillus fungi are present in soil, compost, and decaying vegetation, and they release microscopic spores that are easily inhaled. While most healthy individuals can resist infection, those with conditions such as asthma, cancer, HIV, COPD, cystic fibrosis, or recovering from organ transplants are at heightened risk. When the immune system fails to eliminate the spores, the fungus begins to grow inside the body, potentially leading to aspergillosis, a condition that can cause severe lung damage, organ failure, and even death. The infection is particularly dangerous because it is difficult to detect. Symptoms such as fever, coughing, and fatigue can mimic more common illnesses, delaying diagnosis and treatment. Mortality rates for invasive aspergillosis range from 20% to 40%, according to studies. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Eat 1 Teaspoon Every Night, See What Happens A Week Later [Video] getfittoday Undo Climate Change Accelerating Spread A recent study by researchers at the University of Manchester has identified climate change as a major factor behind the expanding presence of Aspergillus species. Using climate models and simulations, the team predicts that rising global temperatures and changing weather patterns will push the fungus into new regions. Parts of North America, Europe, China, and Russia are expected to face greater exposure within the next 15 years. Two key species—Aspergillus flavus and Aspergillus fumigatus—are of particular concern. The former thrives in hotter climates and could expand by 16%, while the latter, more common in temperate regions, could grow by as much as 77.5%, potentially affecting 9 million more people in Europe alone. Meanwhile, countries such as Brazil and regions in Africa may become too hot for some Aspergillus species to survive, highlighting the unpredictable ecological impact. Urban Centers and Vulnerable Regions at Risk Urban areas like New York, Los Angeles, and other densely populated cities are particularly vulnerable due to aging infrastructure and concentrated populations. California has reported the highest levels of exposure, with factors like humidity and intensive agricultural activity aiding fungal growth. States including Florida, Georgia, Louisiana, and Texas have also detected the presence of the fungus. Researchers say that continued fossil fuel use and lack of mitigation efforts could worsen the spread of these pathogens. Norman van Rijn, a researcher involved in the study, emphasized that fungal pathogens have been understudied for too long and are now adapting to climate shifts in ways that make them harder to combat.
Time of India
3 hours ago
- Time of India
AI 171 crash: IMA to hold prayer meet for 10 doctors and medical students
Ahmedabad: The devastating AI 171 airplane crash claimed the lives of six doctors and four medical students, officials from the Gujarat state branch of the Indian Medical Association (GSB-IMA) said. Tired of too many ads? go ad free now Senior IMA officials announced that a prayer meeting has been organized for Tuesday at 5 pm at the Ahmedabad Medical Association (AMA) on Ashram Road, in association with the AMA. The officials, along with members of the medical fraternity from Ahmedabad and other parts of Gujarat, will participate in the event. According to IMA and AMA officials, the deceased include Dr Himanshu Sheth from Anand, Dr Hitesh Shah from Surat, Dr Taskin Saiyed from Ahmedabad and Dr Bhavesh Senta from Surat. The deceased passengers included the couple, Dr Prateek Joshi and Dr Komi Vyas from Rajasthan. The plane had crashed into the BJ Medical College hostel, claiming the lives of students Manav Bhadu, Jayprakash Chaudhary, Aryan Rajput and Rakesh Dihora, who were having their lunch at the time. Dr Tushar Patel, a pulmonologist and critical care specialist from the city, said that GSB-IMA and AMA members volunteered at Civil Hospital immediately after the incident and worked closely with the medical team.
The Hindu
6 hours ago
- The Hindu
Lupin, China's SUP ink pact for COPD drug Tiotropium DPI
Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese market. Under the partnership that will enable Lupin to expand footprint in China, SUP will obtain regulatory approvals for selling Tiotropium DPI in China. Lupin will be the marketing authorisation holder and responsible for manufacturing of the product. Tiotropium DPI is known for its efficacy in improving lung function and quality of life for patients suffering from respiratory conditions. Their partnership comes in backdrop of increasing prevalence of respiratory conditions, Lupin said in a release on Monday. 'This partnership demonstrates our commitment to developing critical products for the treatment of respiratory diseases such as COPD and establishing our leadership in the global respiratory health sector,' Lupin's President of Corporate Development Fabrice Egros said. SUP president Wang Li said 'by bringing more efficient and superior products to market, we aim to make significant breakthroughs in respiratory disease treatment in China, allowing more patients to benefit from international high-quality and innovative products and enjoy respiratory health.' Lupin shares closed with a gain of less than 1% on the BSE at ₹2,010.55 each on Monday.
